Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 12,000 shares, a growth of 300.0% from the March 31st total of 3,000 shares. Based on an average daily trading volume, of 73,000 shares, the […]
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 100,500 shares, an increase of 233.9% from the January 15th total of 30,100 shares. Based on an average daily volume of 124,700 […]
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totalling 30,100 shares, a decrease of 78.3% from the December 31st total of 138,600 shares. Approximately 2.6% of the company’s stock are short sold. Based on […]
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large decrease in short interest in October. As of October 31st, there was short interest totalling 72,100 shares, a decrease of 24.7% from the October 15th total of 95,700 shares. Based on an average daily trading volume, of 167,400 shares, the […]
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 24,900 shares, a drop of 48.2% from the July 15th total of 48,100 shares. Approximately 0.3% of the company’s shares are short […]